Skip to main content
fr
en
Toggle navigation
Main navigation
Company
Company profile
Management
Our history
Great Place to Work
Science
Scientific approach
Innate Immunity & NK cells
Antibody formats
ANKET: Our NK cell engager Platform
Publications
Products
Pipeline overview
Clinical trials
------------------
Lacutamab
Monalizumab
Avdoralimab
IPH5201
IPH5301
IPH6101
IPH62
------------------
LUMOXITI
Partnering
Investors
Overview
News & Events
Financial and Regulatory Information
General Shareholders Meeting
Share Information
Investor Kit
Corporate Governance
Media
Media hub
All press releases
Media center
Careers
Home
Media
Media center
Nasdaq #BehindTheBell (October 17, 2019)
Nasdaq #BehindTheBell (October 17, 2019)
Wed, 10/30/2019 - 09:45
Category
Corporate
